Related Experiment Video

Updated: Jul 10, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

D Llobet1, N Eritja, M Encinas

  • 1Oncologic Pathology Group, Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.

Oncogene
|November 6, 2007
PubMed

Insights

Casein kinase (CK2) inhibition sensitizes cancer cells to TRAIL-induced apoptosis by reducing FLIP protein levels, leading to proteasome-mediated degradation. This strategy shows promise for enhancing cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in cancer cells.
  • Resistance to TRAIL-induced apoptosis in endometrial carcinoma is linked to elevated FLICE-inhibitory protein (FLIP) levels.

Purpose of the Study:

  • To investigate mechanisms for sensitizing endometrial carcinoma cells to TRAIL-induced apoptosis.
  • To explore the role of casein kinase (CK2) in regulating FLIP levels and TRAIL sensitivity.

Main Methods:

  • Inhibition of CK2 in endometrial carcinoma cells.
  • Assessment of FLIP protein and mRNA levels.
  • Analysis of apoptosis induction via TRAIL and Fas.
  • Proteasome inhibition using MG-132.
  • Forced expression of FLIP.
  • Knockdown of FADD and caspase-8.
  • Testing in primary endometrial carcinoma explants.

Main Results:

  • CK2 inhibition sensitized endometrial carcinoma cells to TRAIL- and Fas-induced apoptosis.
  • CK2 inhibition led to decreased FLIP protein levels, suggesting CK2 regulates FLIP.
  • FLIP downregulation was proteasome-mediated and reduced FLIP mRNA.
  • Restoring FLIP levels re-established resistance to TRAIL and Fas.
  • CK2-induced sensitization required functional DISC formation (FADD and caspase-8).
  • CK2 inhibition sensitized primary endometrial carcinoma explants to TRAIL.

Conclusions:

  • CK2 plays a critical role in regulating endometrial carcinoma cell sensitivity to TRAIL and Fas.
  • CK2 inhibition sensitizes cancer cells to TRAIL-induced apoptosis by promoting FLIP degradation.
  • Targeting CK2 represents a potential therapeutic strategy to overcome TRAIL resistance in endometrial carcinoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...